Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Original Research

Published on 26 Feb 2024

Retrospective analysis of pediatric sepsis and the burden of antimicrobial resistance in Duhok, Kurdistan Region of Iraq

in Pharmacology of Infectious Diseases

Delveen R. Ibrahim
Abdulrhaman T. Saadi
Nizar B. Yahya
Marwa S. Ibrahim
Ali Y. Saeed
Sawsan S. Abdulaziz
Revan Y. Hasqyal
Berivan K. Alarsalani
Khalid S. Ibrahim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347832

2,162 views

Original Research

Published on 21 Feb 2024

Human adenovirus type 3 restores pharmacologically inhibited exosomal cargo in lung carcinoma cells

in Pharmacology of Infectious Diseases

Ayodeji O. Ipinmoroti
Rachana Pandit
Brennetta J. Crenshaw
Brian Sims
Qiana L. Matthews

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1339862

2,169 views

Review

Published on 16 Feb 2024

Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues

in Pharmacology of Infectious Diseases

Clara Appiah
Shitian Chen
Afia Ibnat Pori
Vladimir Retyunskiy
Chimeng Tzeng
Ye Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1359261

4,391 views
5 citations

Original Research

Published on 15 Feb 2024

The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study

in Pharmacology of Infectious Diseases

Chun-Chi Yang
Ya-Wen Tsai
Su-Hung Wang
Jheng-Yan Wu
Ting-Hui Liu
Wan-Hsuan Hsu
Po-Yu Huang
Min-Hsiang Chuang
Ming-Jen Sheu
Chih-Cheng Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1321155

1,585 views
1 citation

Original Research

Published on 06 Feb 2024

Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection

in Pharmacology of Infectious Diseases

Abdelrahim Maen
Betul Gok Yavuz
Yehia I. Mohamed
Abdullah Esmail
Jianming Lu
Amr Mohamed
Asfar S. Azmi
Mohamed Kaseb
Osama Kasseb
Dan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1291212

2,131 views
1 citation

Original Research

Published on 02 Feb 2024

Antibacterial activity of isopropoxy benzene guanidine against Riemerella anatipestifer

in Pharmacology of Infectious Diseases

Yixing Lu
Weimei Qiao
Yaqian Xue
Xiaoxin Hong
Yuhang Jin
Jie Li
Xianfeng Peng
Dongping Zeng
Zhenling Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347250

2,013 views
2 citations

Original Research

Published on 01 Feb 2024

Comparative pharmacokinetics of polymyxin B in critically ill elderly patients with extensively drug-resistant gram-negative bacteria infections

in Pharmacology of Infectious Diseases

Juan Zeng
Bing Leng
Xiaoyan Guan
Shuangyan Jiang
Maoyu Xie
Wenying Zhu
Yue Tang
Lin Zhang
Jing Sha
Tengfei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347130

2,177 views
2 citations

Original Research

Published on 23 Jan 2024

Polymeric nanoparticles containing kojic acid induce structural alterations and apoptosis-like death in Leishmania (Leishmania) amazonensis

in Pharmacology of Infectious Diseases

Poliana Queiroz-Souza
Adan Galue-Parra
Lienne Silveira Moraes
Caroline Gomes Macedo
Ana Paula Drummond Rodrigues
Victor H. S. Marinho
Fabricio H. Holanda
Irlon M. Ferreira
Edilene Oliveira da Silva

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1331240

2,045 views

Systematic Review

Published on 22 Jan 2024

Unraveling the impact of nitric oxide, almitrine, and their combination in COVID-19 (at the edge of sepsis) patients: a systematic review

in Pharmacology of Infectious Diseases

Ying Wang
Qian Yu
Yuan Tian
Shiying Ren
Liping Liu
Chaojie Wei
Renli Liu
Jing Wang
Dong Li
Kun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172447

1,850 views
2 citations

Systematic Review

Published on 18 Jan 2024

Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Edinson Dante Meregildo-Rodriguez
Martha Genara Asmat-Rubio
Victor Hugo Bardales-Zuta
Gustavo Adolfo Vásquez-Tirado

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1298919

1,651 views

Review

Published on 12 Jan 2024

Antibiotic action and resistance: updated review of mechanisms, spread, influencing factors, and alternative approaches for combating resistance

in Pharmacology of Infectious Diseases

Esraa M. Halawa
Mohamed Fadel
Mohammed W. Al-Rabia
Ali Behairy
Nehal A. Nouh
Mohamed Abdo
Rada Olga
Liana Fericean
Ahmed M. Atwa
Mohammad El-Nablaway

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1305294

54,254 views
69 citations

Original Research

Published on 11 Jan 2024

Antifungal activity of the repurposed drug disulfiram against Cryptococcus neoformans

in Pharmacology of Infectious Diseases

Min Peng
Chen Zhang
Yuan-Yuan Duan
Hai-Bo Liu
Xin-Yuan Peng
Qian Wei
Qi-Ying Chen
Hong Sang
Qing-Tao Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1268649

2,926 views

Original Research

Published on 11 Jan 2024

Inhibition of adenovirus transport from the endosome to the cell nucleus by rotenone

in Pharmacology of Infectious Diseases

María Balsera-Manzanero
Francesca Ghirga
Ana Ruiz-Molina
Mattia Mori
Jerónimo Pachón
Bruno Botta
Elisa Cordero
Deborah Quaglio
Javier Sánchez-Céspedes

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1293296

1,975 views
3 citations

Systematic Review

Published on 08 Jan 2024

The efficacy and safety of high-dose isoniazid-containing therapy for multidrug-resistant tuberculosis: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Ming Zhou
Ai-Mei Liu
Xiao-Bing Yang
Cui-Ping Guan
Yan-An Zhang
Mao-Shui Wang
Ya-Li Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1331371

3,041 views
3 citations

Original Research

Published on 29 Dec 2023

Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis

in Pharmacology of Infectious Diseases

Zhenwei Yu
Jieqiong Liu
Haitao Yu
Ling Zhou
Jianping Zhu
Gang Liang
Yi Yang
Ying Zheng
Yun Han
Junjun Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1298397

2,851 views
2 citations

Original Research

Published on 27 Dec 2023

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo

in Pharmacology of Infectious Diseases

Min You
Fentian Chen
Chao Yu
Yuanzhi Chen
Yue Wang
Xue Liu
Xueran Guo
Bing Zhou
Xin Wang
Boya Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1213726

2,433 views